Resiquimod enhances mucosal and systemic immunity against avian infectious bronchitis virus vaccine in the chicken

Adjuvant enhancing mucosal immune response is preferred in controlling many pathogens at the portal of entry. Earlier, we reported that a toll-like-receptor 7 (TLR7) agonist, resiquimod (R-848), stimulated the systemic immunity when adjuvanted with the inactivated Newcastle disease virus vaccine in...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Microb Pathog
Hauptverfasser: Matoo, Javaid Jeelani, Bashir, Khalid, Kumar, Ajay, Krishnaswamy, Narayanan, Dey, Sohini, Chellappa, Madhan Mohan, Ramakrishnan, Saravanan
Format: Artigo
Sprache:Inglês
Veröffentlicht: Elsevier Ltd. 2018
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7127065/
https://ncbi.nlm.nih.gov/pubmed/29635053
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.micpath.2018.04.012
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge